TY - JOUR
T1 - Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients
AU - Saab, Sammy
AU - Ng, Vivian
AU - Landaverde, Carmen
AU - Lee, Sung Jae
AU - Comulada, W. Scott
AU - Arevalo, Jennifer
AU - Durazo, Francisco
AU - Han, Steven Huy
AU - Younossi, Zobari
AU - Busuttil, Ronald W.
PY - 2011/5
Y1 - 2011/5
N2 - Currently, no disease-targeted instrument is available for measuring health-related quality of life (HRQOL) in liver transplant recipients. We developed and tested a post-liver transplant quality of life (pLTQ) instrument. Item selection for the pLTQ instrument was based on responses from liver transplant recipients, 12 liver experts, and a literature search. Impact scores were generated, and a factor analysis was conducted to organize the items into domains. Questions were constructed for each item, and redundant questions were removed. The pLTQ instrument was initially administered to 196 liver transplant patients and then was again administered to 77 patients 6 to 9 months later with a generic HRQOL survey [Medical Outcomes Study Short Form 36 (SF-36)]. Analysis of variance was used to compare the scores of patients at different times since transplantation and with various indications for transplantation. After redundancies were eliminated, the pLTQ instrument included 32 items in 8 domains: Emotional Function, Worry, Medications, Physical Function, Healthcare, Graft Rejection Concern, Financial, and Pain. We found stable pLTQ instrument and SF-36 instrument scores over time. Data 6 to 9 months after the initial assessment indicated stable quality of life outcomes. The pLTQ instrument is applicable to a variety of liver transplant recipients. The questionnaire was tested with a cross-sectional and longitudinal approach.
AB - Currently, no disease-targeted instrument is available for measuring health-related quality of life (HRQOL) in liver transplant recipients. We developed and tested a post-liver transplant quality of life (pLTQ) instrument. Item selection for the pLTQ instrument was based on responses from liver transplant recipients, 12 liver experts, and a literature search. Impact scores were generated, and a factor analysis was conducted to organize the items into domains. Questions were constructed for each item, and redundant questions were removed. The pLTQ instrument was initially administered to 196 liver transplant patients and then was again administered to 77 patients 6 to 9 months later with a generic HRQOL survey [Medical Outcomes Study Short Form 36 (SF-36)]. Analysis of variance was used to compare the scores of patients at different times since transplantation and with various indications for transplantation. After redundancies were eliminated, the pLTQ instrument included 32 items in 8 domains: Emotional Function, Worry, Medications, Physical Function, Healthcare, Graft Rejection Concern, Financial, and Pain. We found stable pLTQ instrument and SF-36 instrument scores over time. Data 6 to 9 months after the initial assessment indicated stable quality of life outcomes. The pLTQ instrument is applicable to a variety of liver transplant recipients. The questionnaire was tested with a cross-sectional and longitudinal approach.
UR - http://www.scopus.com/inward/record.url?scp=79955061411&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955061411&partnerID=8YFLogxK
U2 - 10.1002/lt.22267
DO - 10.1002/lt.22267
M3 - Article
C2 - 21506245
AN - SCOPUS:79955061411
VL - 17
SP - 567
EP - 579
JO - Liver Transplantation
JF - Liver Transplantation
SN - 1527-6465
IS - 5
ER -